A, M., A, B., L, M., M, D. C., C, M., A, B., . . . AM, R. (2022). Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis. Journal of neurology, 269(6), 2840. https://doi.org/10.1007/s00415-022-11003-3
Chicago Style (17th ed.) CitationA, Mariottini, Bertozzi A, Marchi L, Di Cristinzi M, Mechi C, Barilaro A, Massacesi L, and Repice AM. "Effect of Disease-modifying Treatments on Antibody-mediated Response to Anti-COVID19 Vaccination in People with Multiple Sclerosis." Journal of Neurology 269, no. 6 (2022): 2840. https://doi.org/10.1007/s00415-022-11003-3.
MLA (9th ed.) CitationA, Mariottini, et al. "Effect of Disease-modifying Treatments on Antibody-mediated Response to Anti-COVID19 Vaccination in People with Multiple Sclerosis." Journal of Neurology, vol. 269, no. 6, 2022, p. 2840, https://doi.org/10.1007/s00415-022-11003-3.